skip to Main Content

March 2019

This month we touch on topics about hypertension and kidney diseases. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia Clinical Trial of the Effects of Dietary Patterns on Blood Pressure (DASH)

Read more

Now in Clinic

Primary Care at Mid-Valley I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.